Skip to main content
    • Aa
    • Aa

Durability of antidepressant response to vagus nerve stimulation (VNSTM)

  • Harold A. Sackeim (a1) (a2), Stephen K. Brannan (a3), A. John Rush (a4), Mark S. George (a5), Lauren B. Marangell (a6) (a7) and John Allen (a3)...

This study characterized the durability of improvement in patients who responded early or late while receiving vagus nerve stimulation (VNS). In both a pilot and pivotal study, patients were identified who had at least a 50% reduction in symptom scores 3 months (early responders) or 12 months (late responders) after starting VNS. Probabilities were determined for maintenance of response at 12-month and 24-month time-points. Consistency of improvement throughout the 24-month study period was evaluated, testing for change in serial depression ratings. In the pilot study, 30.5%, 23.7% and 45.8% were early responders, later responders, and non-responders, respectively. These rates were 14.6%, 19.5%, and 65.9% in the pivotal trial. The potential confound of alterations in antidepressant treatment was examined in the pivotal trial. In the pilot study, 72.2% and 61.1% of early responders (n=18) were responders at 12 and 24 months, respectively; 78.8% of late responders (n=14) were responders at 24 months. In the pivotal trial, of early responders (n=30), 63.3% and 76.7% maintained response at 12 and 24 months, respectively; of late responders (n=40), 65.0% maintained response at 24 months. Early and late responders had fewer changes in medication than non-responders across the pivotal study period. In both studies, analyses of serial depression ratings showed stable improvement in early and late responders. These samples had exceptional levels of chronicity and treatment resistance. Yet patients who showed substantial clinical benefit maintained the improvement at remarkably high rates. This durability of benefit was not attributable to alterations in other treatments.

Corresponding author
Address for correspondence: H. A. Sackeim, Ph.D., Department of Biological Psychiatry, New York State Psychiatric Institute, 1051 Riverside Drive, Unit 126, New York, NY 10032, USA. Tel.: 01 212 543 5855Fax: 01 212 543 5854E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

DL Dunner , AJ Rush , JM Russel , M Burke , S Woodard , P Wingard , J Allen (2006). Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. Journal of Clinical Psychiatry 67, 688695.

AJ Flint , SL Rifat (1997). The effect of treatment on the two-year course of late-life depression. British Journal of Psychiatry 170, 268272.

AJ Flint , SL Rifat (2001). Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression. Depression & Anxiety 13, 125131.

MS George , AJ Rush , LB Marangell , HA Sackeim , SK Brannan , SM Davis , R Howland , MA Kling , F Moreno , B Rittberg , (2005). A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biological Psychiatry 58, 364373.

M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278296.

CR Hernandez , GS Smith , PR Houck , BG Pollock , B Mulsant , MA Dew , CF Reynolds 3rd (2000). The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome. Psychiatry Research 97, 4149.

MM Husain , AJ Rush , M Fink , R Knapp , G Petrides , T Rummans , MM Biggs , K O'Connor , K Rasmussen , M Litle , (2004). Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. Journal of Clinical Psychiatry 65, 485491.

K Kawai , H Shimizu , T Maehara , H Murakami (2002). Outcome of long-term vagus nerve stimulation for intractable epilepsy. Neurologia Medico-Chirurgica 42, 481489.

WV McCall , DM Reboussin , RD Weiner , HA Sackeim (2000). Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Archives of General Psychiatry 57, 438444.

GL Morris 3rd, WM Mueller (1999). Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01–E05. Neurology 53, 17311735.

Z Nahas , LB Marangell , MM Husain , AJ Rush , HA Sackeim , SH Lisanby , JM Martinez , MS George (2005). Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry 66, 10971104.

SS Newton , RS Duman (2004). Regulation of neurogenesis and angiogenesis in depression. Current Neurovascular Research 1, 261267.

MA Posternak , M Zimmerman , GI Keitner , IW Miller (2002). A reevaluation of the exclusion criteria used in antidepressant efficacy trials. American Journal of Psychiatry 159, 191200.

FM Quitkin , PJ McGrath , JW Stewart , K Ocepek-Welikson , BP Taylor , E Nunes , D Delivannides , V Agosti , SJ Donovan , D Ross , (1998). Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications. British Journal of Psychiatry 173, 242248.

AJ Rush , DE Giles , MA Schlesser , CL Fulton , J Weissenburger , C Burns (1985). The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Research 18, 6587.

AJ Rush , HA Sackeim , LB Marangell , MS George , SK Brannan , SM Davis , P Lavori , R Howland , MA Kling , B Rittberg , (2005b). Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biological Psychiatry 58, 355363.

HA Sackeim , RF Haskett , BH Mulsant , ME Thase , JJ Mann , HM Pettinati , RM Greenberg , RR Crowe , TB Cooper , J Prudic (2001b). Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. Journal of the American Medical Association 285, 12991307.

HA Sackeim , J Prudic , DP Devanand , P Decina , B Kerr , S Malitz (1990). The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. Journal of Clinical Psychopharmacology 10, 96104.

HA Sackeim , J Prudic , DP Devanand , JE Kiersky , L Fitzsimons , BJ Moody , MC McElhiney , EA Coleman , JM Settembrino (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine 328, 839846.

HA Sackeim , J Prudic , DP Devanand , MS Nobler , SH Lisanby , S Peyser , L Fitzsimons , BJ Moody , J Clark (2000). A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Archives of General Psychiatry 57, 425434.

HA Sackeim , AJ Rush , MS George , LB Marangell , MM Husain , Z Nahas , CR Johnson , S Seidman , C Giller , S Haines , (2001a). Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25, 713728.

L Santarelli , M Saxe , C Gross , A Surget , F Battaglia , S Dulawa , N Weisstaub , J Lee , R Duman , O Arancio , (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805809.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *